Industry · municipality
The Pharmacy Industry in Vennesla: Current Status and Future Outlook
Analysis of economy, companies, and development trends in the pharmacy industry in Vennesla Municipality (Agder). This includes sales development, organizational forms, geographic distribution, and operational statistics for the industry in the municipality. The article also prov
Executive Summary
Overview of the Pharmacy Industry in Vennesla
Vennesla has a stable and growing pharmacy industry with two registered companies: Vitusapotek Vennesla and Boots Apotek Vennesla. Over the past five years, sales have grown by 11.4% from 2024 to 2025, indicating a positive trend. Employment figures have been more variable, but there has been a slight increase from 21 to 22 employees between 2024 and 2026. The industry has a high average gross profit margin of 7010%, suggesting that pharmacies operate with high margins.
Key Figures and Development
- Sales: NOK 76.1 million in 2025 (an increase of 11.4% from 2024)
- Number of Employees: 22 employees in 2026 (an increase of 4.8% from 2024)
- Organizational Form: Both companies are AS (Stock Company)
- Bankruptcies: No bankruptcies registered in the pharmacy industry in Vennesla
Economic Overview
The pharmacy industry in Vennesla has shown stable economic development in recent years. Sales have increased by 11.4% from 2024 to 2025, and there is a positive trend in recent years. Employment figures have been more variable, but there has been a slight increase from 21 to 22 employees between 2024 and 2026. The industry has a high average gross profit margin of 7010%, suggesting that pharmacies operate with high margins.
Development Over Time
| Year | Sales (NOK) | Number of Employees |
|---|---|---|
| 2016 | 50.9M | 26 |
| 2017 | 61.6M | 26 |
| 2018 | 53.4M | 19 |
| 2019 | 54.5M | 19 |
| 2020 | 56.4M | 19 |
| 2021 | 60.2M | 18 |
| 2022 | 63.0M | 19 |
| 2023 | 65.2M | 21 |
| 2024 | 68.3M | 21 |
| 2025 | 76.1M | 22 |
| 2026 | 76.1M | 22 |
Economic Indicators
- EBITDA Margin: 4% (average)
- Operating Profit per Employee: NOK 3.2M (average)
- Total Debt: NOK 19.3M (for the entire industry)
- Equity: NOK 8.8M (for the entire industry)
Companies in the Industry
Vennesla has two registered pharmacy companies:
- Vitusapotek Vennesla (Torsbyvegen 3, Vennesla)
- Organizational Form: AS
- Founded: April 15, 2007
- Number of Employees: 14
- Sales: NOK 47.3M
- EBITDA: NOK 2.9M
- Gross Profit: NOK 3,729.8M
- Equity: NOK 4.4M
- Total Debt: NOK 13.4M
- Boots Apotek Vennesla (Sentrumsvegen 41, Vennesla)
- Organizational Form: AS
- Founded: December 31, 1965
- Number of Employees: 8
- Sales: NOK 25.0M
- EBITDA: NOK 451.5K
- Gross Profit: NOK 1,335.9M
- Equity: NOK 4.3M
- Total Debt: NOK 5.9M
Organizational Form
- AS (Stock Company): 2 companies (100% of the industry)
- Number of Employees: 22 total
- Total Sales: NOK 72.3M
- Total Equity: NOK 8.8M
- Total Debt: NOK 19.3M
Business Geography
The pharmacy industry in Vennesla is concentrated in the municipality's central area. Registered activity is present in the following locations:
- Vennesla: 2 companies, 22 employees, NOK 72.3M in sales
Distribution by Neighborhood
| Location | Number of Companies | Number of Employees | Sales (NOK) |
|---|---|---|---|
| Vennesla | 2 | 22 | 72.3M |
Geographical Observations
- Activity is concentrated in the main town of Vennesla
- No activity registered in other neighborhoods
- High concentration of employees and sales in the main town
Business Dynamics
The pharmacy industry in Vennesla has shown stable development in recent years, with no bankruptcies registered. However, there are some variations in employment trends:
- Employment Trends: Reduction from 26 to 18 employees between 2016 and 2021, followed by an increase to 22 employees in 2026
- Sales Trends: Greater variations, but an increase from NOK 50.9M in 2016 to NOK 76.1M in 2025
Bankruptcies and Operational Risk
- No bankruptcies registered for the pharmacy industry in Vennesla
- Stable operational results: EBITDA margin of 4% (average)
- High gross profit margin: 7010% (average)
- Low operational risk: No bankruptcies and stable sales development
Outlook
The pharmacy industry in Vennesla shows signs of stable growth and high operational efficiency. With an 11.4% increase in sales from 2024 to 2025 and an increase in the number of employees, there are positive signals for the future. However, it is important to note that competition is strongly concentrated in two large companies, which may affect opportunities for new entrants.
Opportunities and Challenges
- Opportunities: Increasing sales, high gross profit margin, stable operations
- Challenges: Strong competition from existing companies, variations in employment trends
Recommendation
For entrepreneurs considering establishing themselves in the pharmacy industry in Vennesla, it may be profitable to analyze potential locations and operational models. SmartGrunder can help find optimal addresses and assess operational conditions in the municipality.
Conclusion
The pharmacy industry in Vennesla has shown stable and positive development in recent years, with increasing sales and high operational efficiency. With two large companies in the industry and no bankruptcies registered, it is a stable and attractive market for both existing and new players. The future looks positive with an expected increase in sales and number of employees. For entrepreneurs, it may be profitable to explore opportunities in the municipality, and SmartGrunder can help find optimal addresses and assess operational conditions.